Who
Carol Schafer
Director
Company insider
Files Form 4 as: Director, Immunome; Director, Kura Oncology; Director, Insmed; Director, Repare Therapeutics; Director, Idera Pharmaceuticals; Director, Five Prime Therapeutics.
In numbers
- Trades disclosed
- 51
- Buys
- 2
- Sells
- 0
- Bought
- $177K
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 18 Dec 2018
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,897 at $0.00 | filing |
| 4 Jun 2026filed 4 Jun 2026 | KURA Kura Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 4 Jun 2026filed 4 Jun 2026 | KURA Kura Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —3,305 | filing |
| 13 May 2026filed 15 May 2026 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —3,305 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare TherapeuticsBiotechnology | SEC FORM 4 Code D | —8,000 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —37,941 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code D | —37,941 at $0.00 | filing |
| 28 Jan 2026filed 28 Jan 2026 | Repare Therapeutics | SEC FORM 4 Code D | —8,000 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,864 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | KURA Kura Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,500 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —5,058 | filing |
| 17 Jun 2024filed 20 Jun 2024 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code A | —27,200 at $0.00 | filing |
| 13 Jun 2024filed 18 Jun 2024 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,333 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | KURA Kura Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 13 May 2024filed 15 May 2024 | INSM InsmedBiotechnology | SEC FORM 4 Code A | —13,162 | filing |
| 2 Jan 2024filed 4 Jan 2024 | IMNM Immunomeoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,934 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | Repare Therapeuticsoption or derivative | SEC FORM 4 Code A | —27,200 at $0.00 | filing |
| 31 May 2023filed 2 Jun 2023 | KURA Kura Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.